Literature DB >> 6113953

Lysyl oxidase activity in the mouse uterine cervix is physiologically regulated by estrogen.

H Ozasa, T Tominaga, T Nishimura, T Takeda.   

Abstract

Lysyl oxidase activity in the mouse cervix was examined during the estrous cycle, pregnancy, and the postpartum period. It was highest in estrus and lowest in diestrus. On day 1 of pregnancy, the activity was comparable to that seen in estrus. It then declined continuously until day 17 of pregnancy, when it was approximately equal to that seen during diestrus. The activity showed a slight increase toward term, then a precipitous increase occurred on the first postpartum day. The activity fell by the seventh postpartum day to a value comparable to that seen in diestrus. Enzyme activity fell to one fourth of its former value 3 days after ovariectomy. The injection of 1 microgram 17 beta-estradiol or more in 0.9% NaCl 10 days after ovariectomy raised the activity, in 18 h, to the level seen in estrus. One milligram of progesterone had no effect on the enzyme activity, but a combination of 1 microgram 17 beta-estradiol and 1 mg progesterone raised the activity to that seen with 1 microgram 17 beta-estradiol alone. These results suggest that lysyl oxidase activity in the mouse cervix is under the control of estrogen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113953     DOI: 10.1210/endo-109-2-618

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Second harmonic generation imaging as a potential tool for staging pregnancy and predicting preterm birth.

Authors:  Meredith L Akins; Katherine Luby-Phelps; Mala Mahendroo
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170

2.  Cervical softening during pregnancy: regulated changes in collagen cross-linking and composition of matricellular proteins in the mouse.

Authors:  Meredith L Akins; Katherine Luby-Phelps; Ruud A Bank; Mala Mahendroo
Journal:  Biol Reprod       Date:  2011-01-19       Impact factor: 4.285

3.  Steroid Hormones Are Key Modulators of Tissue Mechanical Function via Regulation of Collagen and Elastic Fibers.

Authors:  Shanmugasundaram Nallasamy; Kyoko Yoshida; Meredith Akins; Kristin Myers; Renato Iozzo; Mala Mahendroo
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

4.  Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene.

Authors:  S Contente; K Kenyon; P Sriraman; S Subramanyan; R M Friedman
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

Review 5.  Mechanics of cervical remodelling: insights from rodent models of pregnancy.

Authors:  Kyoko Yoshida; Charles Jayyosi; Nicole Lee; Mala Mahendroo; Kristin M Myers
Journal:  Interface Focus       Date:  2019-08-16       Impact factor: 3.906

6.  Increase in pyridinoline cross-linking of mouse bone collagen induced by estrogen.

Authors:  K Shimizu; K Higuchi; T Yamamuro; T Ohtsuji; T Takeda
Journal:  Experientia       Date:  1982-07-15

Review 7.  Cervical remodeling during pregnancy and parturition.

Authors:  Brenda Timmons; Meredith Akins; Mala Mahendroo
Journal:  Trends Endocrinol Metab       Date:  2010-02-19       Impact factor: 12.015

Review 8.  Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus.

Authors:  M Saito; K Marumo
Journal:  Osteoporos Int       Date:  2010-02       Impact factor: 4.507

9.  Stimulation of lysyl oxidase (EC 1.4.3.13) activity by testosterone and characterization of androgen receptors in cultured calf aorta smooth-muscle cells.

Authors:  R E Bronson; S D Calaman; A M Traish; H M Kagan
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

10.  Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia.

Authors:  M Saito; K Marumo; S Soshi; Y Kida; C Ushiku; A Shinohara
Journal:  Osteoporos Int       Date:  2009-05-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.